BioCatalyst

HS-20089, Paclitaxel, Doxorubicin, Topotecan — catalyst calendar

1 verified catalyst event(s) referencing HS-20089, Paclitaxel, Doxorubicin, Topotecan, each linked to its official source. Verified as of 2026-11-02.

Upcoming

DateEventCompanyDrugOfficial source & verification
2027-03-07
in 4mo
ESTIMATED
 READOUT
HS-20089 for Injection in Patients With Platinum-Resistant Recurrent Epithelial
Phase 3 · Ovarian Cancer
 Hansoh BioMedical R&D Company HS-20089, Paclitaxel, Doxorubicin, Topot ClinicalTrials.gov ↗
✓ Source-checked 2026-11-02
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.